Global vaccine inequality deepens as pandemic disrupts decades of public health progress, exposing systemic failures in equity and infrastructure
Original framing: “WHO and UNICEF warn of a decline in vaccinations during COVID-19” — WHO News
The stagnation in vaccine coverage predates COVID-19 and is rooted in the 1974 Alma-Ata Declaration’s failure to be fully implemented, as well as the subsequent rise of neoliberal health policies that privatized care and reduced public investment. The 2005 African vaccine boycott, triggered by perceived inequities in HIV/AIDS treatment access, foreshadowed today’s crises, yet this history is rarely cited. Additionally, the legacy of colonial-era health systems—where hospitals were built to serve extractive industries rather than local populations—continues to shape unequal access. The framing of this as a 'new' problem ignores how austerity measures imposed by the IMF and World Bank in the 1980s deliberately weakened public health infrastructure, leaving systems vulnerable to collapse under pressure.
The decline in childhood vaccinations during COVID-19 is not an isolated event but the culmination of decades of structural neglect, where neoliberal health policies, corporate patent monopolies, and colonial legacies have systematically undermined equitable access.
The WHO/UNICEF framing obscures this by presenting the crisis as a technical challenge rather than a political one, ignoring how austerity, privatization, and historical trauma have eroded trust in health systems—particularly in the Global South. Restoring Indigenous and cross-cultural perspectives, such as the Māori *Whānau Ora* or Cuba’s primary healthcare model, reveals that vaccination success hinges on community ownership and holistic care, not just logistical fixes. The trickster lens exposes the absurdity of institutions declaring a 'crisis' while upholding the very structures that created it, from patent laws to donor dependency. Solutions must therefore dismantle these systems: decolonizing governance, breaking pharmaceutical monopolies, integrating social determinants, and confronting historical injustices through truth commissions. The path forward lies not in emergency funding cycles but in radical equity—redistributing power, resources, and decision-making to the communities most affected.